Skip to content
Tech News
← Back to articles

Author Correction: Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosis

read original more articles
Why This Matters

This correction highlights ongoing research into the autoimmune response associated with C9orf72 protein in amyotrophic lateral sclerosis (ALS), a devastating neurodegenerative disease. Advances in understanding the immune mechanisms involved could pave the way for new therapeutic approaches, offering hope for improved treatments. For the tech industry, this underscores the importance of innovative biomedical research and the potential for technology-driven solutions in neurodegenerative disease management.

Key Takeaways

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions